Implementing ustekinumab biosimilar

Event 4 September 2024Location Online via WebEx at 12:30 - 14:00

This webinar provided information and guidance to support organisations switch to the best value ustekinumab biosimilar

Date

4 September 2024

Location

Online via WebEx at 12:30 - 14:00

About the event

The NHS England National framework for ustekinumab is due to commence on 1 September 2024. Speakers shared information and guidance to support implementation across the integrated care system. Attendees were able to ask questions. 

Why it’s important

Implementation of ustekinumab biosimilar will require collaborative working across the system. Extra capacity may be required to support additional work associated with the biosimilar introduction so that existing services are not adversely affected. Implementation and use of biosimilar medicines offer the NHS opportunities to deliver better value for certain conditions. 

What was covered

  • An implementation checklist was shared.
  • How homecare providers can support was described.
  • SPS resources to support implementation was demonstrated.

Speakers

A range of speakers from SPS and other organisations helped to run this event.

Non-SPS speakers

Joe Bassett

Assistant Director of Procurement, Pharmacy and Healthcare Services; Chair, National Homecare Medicines Committee

SPS speakers

Contact us

Please contact the Admin Team if you have any questions.

Print this page